Dermatologic care for lesbian, gay, bisexual, and transgender persons

Epidemiology, screening, and disease prevention
      Lesbian, gay, bisexual, and transgender (LGBT) persons face important health issues relevant to dermatologists. Men who have sex with men (MSM) are at higher risk of certain infectious diseases, including HIV, syphilis and other sexually transmitted diseases (STDs), methicillin-resistant Staphylococcus aureus infections, and invasive meningococcal disease, and might be at higher risk of non-infectious conditions, including skin cancer. Recommendations for preventive health care, including screening for HIV and other STDs, sexual health-related vaccinations, and HIV pre-exposure prophylaxis, differ for MSM compared with non-MSM. Women who have sex with women experience disparities in STDs, including chlamydia and HPV. Transgender patients have unique, and often unmet, dermatologic needs during gender transition (also called gender affirmation), related to hormonal therapy and gender-affirming surgery. Familiarity with LGBT health issues and disease-prevention guidelines can enable dermatologists to provide medically appropriate and culturally competent care to LGBT persons.

      Key words

      Abbreviations used:

      CDC (Centers for Disease Control and Prevention), HHV-8 (human herpesvirus-8), HPV (human papillomavirus), HSV-2 (herpes simplex virus type 2), LGBT (lesbian, gay, bisexual, and transgender), MRSA (methicillin-resistant Staphylococcus aureus), MSM (men who have sex with men), nPEP (nonoccupational postexposure prophylaxis), PrEP (preexposure prophylaxis), STD (sexually transmitted disease), USPSTF (US Preventive Services Task Force), WSW (women who have sex with women)
      To read this article in full you will need to make a payment
      AAD Member Login
      AAD Members, full access to the journal is a member benefit. Use your society credentials to access all journal content and features
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Katz K.A.
        • Furnish T.J.
        Dermatology-related epidemiologic and clinical concerns of men who have sex with men, women who have sex with women, and transgender individuals.
        Arch Dermatol. 2005; 141: 1303-1310
        • Centers for Disease Control and Prevention
        CDC Fact Sheet: HIV among Gay and Bisexual Men.
        (Available at:)
        • Centers for Disease Control and Prevention
        Sexually transmitted diseases treatment guidelines, 2015.
        MMWR Morb Mortal Wkly Rep. 2015; 64 (Available at:)
        • Rosenberg E.S.
        • Grey J.A.
        • Sanchez T.H.
        • Sullivan P.S.
        Rates of prevalent HIV infection, prevalent diagnoses, and new diagnoses among men who have sex with men in US states, metropolitan statistical areas, and counties, 2012-2013.
        JMIR Public Health Surveill. 2016; 2: e22
        • Centers for Disease Control and Prevention
        CDC Fact Sheet: Trends in U.S. HIV Diagnoses, 2005-2014.
        (Available at:)
        • Xu F.
        • Sternberg M.R.
        • Markowitz L.E.
        Men who have sex with men in the United States: demographic and behavioral characteristics and prevalence of HIV and HSV-2 infection: results from National Health and Nutrition Examination Survey 2001-2006.
        Sex Transm Dis. 2010; 37: 399-405
        • Machalek D.A.
        • Poynten M.
        • Jin F.
        • et al.
        Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis.
        Lancet Oncol. 2012; 13: 487-500
      1. SEER Cancer Stat Facts: Anal Cancer.
        (Available at:)
        • Sonawane K.
        • Suk R.
        • Chiao E.Y.
        • et al.
        Oral human papillomavirus infection: differences in prevalence between sexes and concordance with genital human papillomavirus infection, NHANES 2011 to 2014.
        Ann Intern Med. 2017; 167: 714-724
        • Lanternier F.
        • Lebbe C.
        • Schartz N.
        • et al.
        Kaposi's sarcoma in HIV-negative men having sex with men.
        AIDS. 2008; 22: 1163-1168
        • Maurer T.
        • Ponte M.
        • Leslie K.
        HIV-associated Kaposi's sarcoma with a high CD4 count and a low viral load.
        N Engl J Med. 2007; 357: 1352-1353
        • Centers for Disease Control and Prevention
        Hepatitis Fact Sheet for Gay and Bisexual Men.
        (Available at:)
        • Hagan H.
        • Jordan A.E.
        • Neurer J.
        • Cleland C.M.
        Incidence of sexually transmitted hepatitis C virus infection in HIV-positive men who have sex with men.
        AIDS. 2015; 29: 2335-2345
        • Centers for Disease Control and Prevention
        Sexually Transmitted Disease Surveillance 2016.
        U.S. Department of Health and Human Services, Atlanta, GA2017 (Available at:)
        • Grey J.A.
        • Bernstein K.T.
        • Sullivan P.S.
        • et al.
        Rates of primary and secondary syphilis among white and black non-hispanic men who have sex with men, US states, 2014.
        J Acquir Immune Defic Syndr. 2017; 76: e65-e73
        • Patton M.E.
        • Kidd S.
        • Llata E.
        • et al.
        Extragenital gonorrhea and chlamydia testing and infection among men who have sex with men--STD Surveillance Network, United States, 2010-2012.
        Clin Infect Dis. 2014; 58: 1564-1570
        • David M.Z.
        • Daum R.S.
        Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic.
        Clin Microbiol Rev. 2010; 23: 616-687
        • Simon M.S.
        • Weiss D.
        • Gulick R.M.
        Invasive meningococcal disease in men who have sex with men.
        Ann Intern Med. 2013; 159: 300-301
        • Ackers M.L.
        • Greenberg A.E.
        • Lin C.Y.
        • et al.
        High and persistent HIV seroincidence in men who have sex with men across 47 U.S. cities.
        PLoS One. 2012; 7: e34972
        • Hecht F.M.
        • Busch M.P.
        • Rawal B.
        • et al.
        Use of laboratory tests and clinical symptoms for identification of primary HIV infection.
        AIDS. 2002; 16: 1119-1129
        • Rigopoulos D.
        • Paparizos V.
        • Katsambas A.
        Cutaneous markers of HIV infection.
        Clin Dermatol. 2004; 22: 487-498
        • Centers for Disease Control and Prevention
        Sexually Transmitted Disease Surveillance 2016.
        U.S. Department of Health and Human Services, Atlanta, GA2017 (Available at:)
        • Taylor M.M.
        • Aynalem G.
        • Olea L.M.
        • He P.
        • Smith L.V.
        • Kerndt P.R.
        A consequence of the syphilis epidemic among men who have sex with men (MSM): neurosyphilis in Los Angeles, 2001-2004.
        Sex Transm Dis. 2008; 35: 430-434
        • Centers for Disease Control and Prevention
        Clinic-based testing for rectal and pharyngeal Neisseria gonorrhoeae and Chlamydia trachomatis infections by community-based organizations--five cities, United States, 2007.
        MMWR Morb Mortal Wkly Rep. 2009; 58: 716-719
        • Park J.
        • Marcus J.L.
        • Pandori M.
        • Snell A.
        • Philip S.S.
        • Bernstein K.T.
        Sentinel surveillance for pharyngeal chlamydia and gonorrhea among men who have sex with men–San Francisco, 2010.
        Sex Transm Dis. 2012; 39: 482-484
        • Brown T.J.
        • Yen-Moore A.
        • Tyring S.K.
        An overview of sexually transmitted diseases. Part I.
        J Am Acad Dermatol. 1999; 41: 511-532
        • Nieuwenhuis R.F.
        • Ossewaarde J.M.
        • Gotz H.M.
        • et al.
        Resurgence of lymphogranuloma venereum in Western Europe: an outbreak of Chlamydia trachomatis serovar l2 proctitis in The Netherlands among men who have sex with men.
        Clin Infect Dis. 2004; 39: 996-1003
        • de Vries H.J.
        • Zingoni A.
        • Kreuter A.
        • Moi H.
        • White J.A.
        European Branch of the International Union against Sexually Transmitted Infections et al. 2013 European guideline on the management of lymphogranuloma venereum.
        J Eur Acad Dermatol Venereol. 2015; 29: 1-6
        • Centers for Disease Control and Prevention
        Lymphogranuloma venereum among men who have sex with men–Netherlands, 2003-2004.
        MMWR Morb Mortal Wkly Rep. 2004; 53: 985-988
        • Pathela P.
        • Blank S.
        • Schillinger J.A.
        Lymphogranuloma venereum: old pathogen, new story.
        Curr Infect Dis Rep. 2007; 9: 143-150
        • Saxon C.
        • Hughes G.
        • Ison C.
        • UK LGV Case-Finding Group
        Asymptomatic lymphogranuloma venereum in men who have sex with men, United Kingdom.
        Emerg Infect Dis. 2016; 22: 112-116
        • Galindo G.R.
        • Casey A.J.
        • Yeung A.
        • Weiss D.
        • Marx M.A.
        Community associated methicillin resistant Staphylococcus aureus among New York City men who have sex with men: qualitative research findings and implications for public health practice.
        J Community Health. 2012; 37: 458-467
        • Centers for Disease Control and Prevention
        Outbreaks of community-associated methicillin-resistant Staphylococcus aureus skin infections--Los Angeles County, California, 2002-2003.
        MMWR Morb Mortal Wkly Rep. 2003; 52: 88
        • Szumowski J.D.
        • Wener K.M.
        • Gold H.S.
        • et al.
        Methicillin-resistant Staphylococcus aureus colonization, behavioral risk factors, and skin and soft-tissue infection at an ambulatory clinic serving a large population of HIV-infected men who have sex with men.
        Clin Infect Dis. 2009; 49: 118-121
        • Freeman E.E.
        • Weiss H.A.
        • Glynn J.R.
        • Cross P.L.
        • Whitworth J.A.
        • Hayes R.J.
        Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies.
        AIDS. 2006; 20: 73-83
        • Celum C.
        • Wald A.
        • Hughes J.
        • et al.
        Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial.
        Lancet. 2008; 371: 2109-2119
        • Viens L.J.
        • Henley S.J.
        • Watson M.
        • et al.
        Human papillomavirus-associated cancers - United States, 2008-2012.
        MMWR Morb Mortal Wkly Rep. 2016; 65: 661-666
        • Goldstone S.
        • Palefsky J.M.
        • Giuliano A.R.
        • et al.
        Prevalence of and risk factors for human papillomavirus (HPV) infection among HIV-seronegative men who have sex with men.
        J Infect Dis. 2011; 203: 66-74
        • Folaranmi T.A.
        • Kretz C.B.
        • Kamiya H.
        • et al.
        Increased risk for meningococcal disease among men who have sex with men in the United States, 2012-2015.
        Clin Infect Dis. 2017; 65: 756-763
        • Tsang R.S.
        • Kiefer L.
        • Law D.K.
        • et al.
        Outbreak of serogroup C meningococcal disease caused by a variant of Neisseria meningitidis serotype 2a ET-15 in a community of men who have sex with men.
        J Clin Microbiol. 2003; 41: 4411-4414
        • Kamiya H.
        • MacNeil J.
        • Blain A.
        • et al.
        Meningococcal disease among men who have sex with men - United States, January 2012-June 2015.
        MMWR Morb Mortal Wkly Rep. 2015; 64: 1256-1257
        • Martin J.N.
        • Ganem D.E.
        • Osmond D.H.
        • Page-Shafer K.A.
        • Macrae D.
        • Kedes D.H.
        Sexual transmission and the natural history of human herpesvirus 8 infection.
        N Engl J Med. 1998; 338: 948-954
        • Engels E.A.
        • Atkinson J.O.
        • Graubard B.I.
        • et al.
        Risk factors for human herpesvirus 8 infection among adults in the United States and evidence for sexual transmission.
        J Infect Dis. 2007; 196: 199-207
        • Gogineni E.
        • Marshall V.
        • Miley W.
        • et al.
        Quantitative determinations of anti-Kaposi sarcoma-associated herpesvirus antibody levels in men who have sex with men.
        Diagn Microbiol Infect Dis. 2013; 76: 56-60
        • Regamey N.
        • Cathomas G.
        • Schwager M.
        • Wernli M.
        • Harr T.
        • Erb P.
        High human herpesvirus 8 seroprevalence in the homosexual population in Switzerland.
        J Clin Microbiol. 1998; 36: 1784-1786
        • Rohner E.
        • Wyss N.
        • Trelle S.
        • et al.
        HHV-8 seroprevalence: a global view.
        Syst Rev. 2014; 3: 11
        • Dogra S.
        • Jindal R.
        Cutaneous manifestations of common liver diseases.
        J Clin Exp Hepatol. 2011; 1: 177-184
        • Urbanus A.T.
        • van Houdt R.
        • van de Laar T.J.
        • Coutinho R.A.
        Viral hepatitis among men who have sex with men, epidemiology and public health consequences.
        Euro Surveill. 2009; 14
        • Corey L.
        • Holmes K.K.
        Sexual transmission of hepatitis A in homosexual men: incidence and mechanism.
        N Engl J Med. 1980; 302: 435-438
        • Yeung H.
        • Chen S.C.
        Disparities in sunburns, photoprotection, indoor tanning, and skin cancer screening among U.S. men and women in same- and opposite-sex relationships [abstract].
        The Journal of investigative dermatology. 2015; 135: S49
        • Mansh M.
        • Katz K.A.
        • Linos E.
        • Chren M.M.
        • Arron S.
        Association of skin cancer and indoor tanning in sexual minority men and women.
        JAMA Dermatol. 2015; 151: 1308-1316
        • Yeung H.
        • Chen S.C.
        Sexual orientation and indoor tanning device use: a population-based study.
        JAMA Dermatol. 2016; 152: 99-101
        • Mansh M.
        • Arron S.T.
        Indoor tanning and melanoma: are gay and bisexual men more at risk?.
        Melanoma Management. 2016; 3: 89-92
        • Blashill A.J.
        Indoor tanning and skin cancer risk among diverse US youth: results from a National sample.
        JAMA Dermatol. 2017; 153: 344-345
        • Blashill A.J.
        • Pagoto S.
        Skin cancer risk in gay and bisexual men: a call to action.
        JAMA Dermatol. 2015; 151: 1293-1294
        • Colfax G.
        • Coates T.J.
        • Husnik M.J.
        • et al.
        Longitudinal patterns of methamphetamine, popper (amyl nitrite), and cocaine use and high-risk sexual behavior among a cohort of san francisco men who have sex with men.
        J Urban Health. 2005; 82: i62-i70
        • Schauber J.
        • Herzinger T.
        ‘Poppers’ dermatitis.
        Clin Exp Dermatol. 2012; 37: 587-588
        • Latini A.
        • Lora V.
        • Zaccarelli M.
        • Cristaudo A.
        • Cota C.
        Unusual Presentation of Poppers Dermatitis.
        JAMA Dermatol. 2017; 153: 233-234
        • Vine K.
        • Meulener M.
        • Shieh S.
        • Silverberg N.B.
        Vitiliginous lesions induced by amyl nitrite exposure.
        Cutis. 2013; 91: 129-136
        • Hoegl L.
        • Thoma-Greber E.
        • Poppinger J.
        • Rocken M.
        Butyl nitrite-induced acrocyanosis in an HIV-infected patient.
        Arch Dermatol. 1999; 135: 90-91
        • Hunter L.
        • Gordge L.
        • Dargan P.I.
        • Wood D.M.
        Methaemoglobinaemia associated with the use of cocaine and volatile nitrites as recreational drugs: a review.
        Br J Clin Pharmacol. 2011; 72: 18-26
        • Schwartz B.G.
        • Kloner R.A.
        Drug interactions with phosphodiesterase-5 inhibitors used for the treatment of erectile dysfunction or pulmonary hypertension.
        Circulation. 2010; 122: 88-95
        • Centers for Disease Control and Prevention
        US Public Health Service: Preexposure prophylaxis for the prevention of HIV infection in the United States—2017 Update: a clinical practice guideline.
        (Available at:)
        • DiNenno E.A.
        • Prejean J.
        • Irwin K.
        • et al.
        Recommendations for HIV screening of gay, bisexual, and other men who have sex with men — United States, 2017.
        MMWR Morb Mortal Wkly Rep. 2017; 66: 830-832
        • Bibbins-Domingo K.
        • Grossman D.C.
        • Curry S.J.
        • et al.
        • U.S. Preventive Services Task Force
        Screening for Syphilis Infection in Nonpregnant Adults and Adolescents: US Preventive Services Task Force Recommendation Statement.
        JAMA. 2016; 315: 2321-2327
        • Moyer V.A.
        • U.S. Preventive Services Task Force
        Screening for HIV: U.S. preventive services task force recommendation statement.
        Ann Intern Med. 2013; 159: 51-60
        • Agency for Healthcare Research and Quality and U.S. Preventive Services Task Force
        The Guide to Clinical Preventive Services 2014. Preface.
        (Available at:)
        • U.S. Preventive Services Task Force
        Grade Definitions.
        (Available at:)
        • Markowitz L.E.
        • Dunne E.F.
        • Saraiya M.
        • Centers for Disease Control and Prevention
        Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP).
        MMWR Recomm Rep. 2014; 63: 1-30
        • MacNeil J.R.
        • Rubin L.G.
        • Patton M.
        • Ortega-Sanchez I.R.
        • Martin S.W.
        Recommendations for use of meningococcal conjugate vaccines in HIV-infected persons - Advisory Committee on Immunization Practices, 2016.
        MMWR Morb Mortal Wkly Rep. 2016; 65: 1189-1194
        • Siegler A.J.
        • Wirtz S.S.
        • Weber S.
        • Sullivan P.S.
        Developing a geolocated directory of PrEP-providing clinics: the PrEP Locator Protocol and Operating Procedures.
        JMIR Public Health Surveill. 2017; 3: e58
        • Centers for Disease Control and Prevention
        Updated guidelines for antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV - United States, 2016.
        MMWR Morb Mortal Wkly Rep. 2016; 65: 458
        • Smith D.K.
        • Van Handel M.
        • Wolitski R.J.
        • et al.
        Vital signs: estimated percentages and numbers of adults with indications for preexposure prophylaxis to prevent HIV acquisition--United States, 2015.
        MMWR Morb Mortal Wkly Rep. 2015; 64: 1291-1295
        • Grant R.M.
        • Lama J.R.
        • Anderson P.L.
        • et al.
        Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.
        N Engl J Med. 2010; 363: 2587-2599
        • Volk J.E.
        • Marcus J.L.
        • Phengrasamy T.
        • et al.
        No new HIV infections with increasing use of HIV preexposure prophylaxis in a clinical practice setting.
        Clin Infect Dis. 2015; 61: 1601-1603
        • Jenness S.M.
        • Weiss K.M.
        • Goodreau S.M.
        • et al.
        Incidence of gonorrhea and chlamydia following HIV preexposure prophylaxis among men who have sex with men: a modeling study.
        Clin Infect Dis. 2017; 65: 712-718
        • Everett B.G.
        Sexual orientation disparities in sexually transmitted infections: examining the intersection between sexual identity and sexual behavior.
        Arch Sex Behav. 2013; 42: 225-236
        • Cox P.
        • McNair R.
        Risk reduction as an accepted framework for safer-sex promotion among women who have sex with women.
        Sex Health. 2009; 6: 15-18
        • Marrazzo J.M.
        • Coffey P.
        • Bingham A.
        Sexual practices, risk perception and knowledge of sexually transmitted disease risk among lesbian and bisexual women.
        Perspect Sex Reprod Health. 2005; 37: 6-12
        • Dolan K.A.
        • Davis P.W.
        Nuances and shifts in lesbian women's constructions of STI and HIV vulnerability.
        Soc Sci Med. 2003; 57: 25-38
        • Gorgos L.M.
        • Marrazzo J.M.
        Sexually transmitted infections among women who have sex with women.
        Clin Infect Dis. 2011; 53: S84-S91
        • Koh A.S.
        • Gomez C.A.
        • Shade S.
        • Rowley E.
        Sexual risk factors among self-identified lesbians, bisexual women, and heterosexual women accessing primary care settings.
        Sex Transm Dis. 2005; 32: 563-569
        • Singh D.
        • Fine D.N.
        • Marrazzo J.M.
        Chlamydia trachomatis infection among women reporting sexual activity with women screened in family planning clinics in the Pacific Northwest, 1997 to 2005.
        Am J Public Health. 2011; 101: 1284-1290
        • Xu F.
        • Sternberg M.R.
        • Markowitz L.E.
        Women who have sex with women in the United States: prevalence, sexual behavior and prevalence of herpes simplex virus type 2 infection-results from national health and nutrition examination survey 2001-2006.
        Sex Transm Dis. 2010; 37: 407-413
        • Berger B.J.
        • Kolton S.
        • Zenilman J.M.
        • Cummings M.C.
        • Feldman J.
        • McCormack W.M.
        Bacterial vaginosis in lesbians: a sexually transmitted disease.
        Clin Infect Dis. 1995; 21: 1402-1405
        • Bailey J.V.
        • Farquhar C.
        • Owen C.
        Bacterial vaginosis in lesbians and bisexual women.
        Sex Transm Dis. 2004; 31: 691-694
        • Valanis B.G.
        • Bowen D.J.
        • Bassford T.
        • Whitlock E.
        • Charney P.
        • Carter R.A.
        Sexual orientation and health: comparisons in the women's health initiative sample.
        Archives of family medicine. 2000; 9: 843-853
        • Agenor M.
        • Peitzmeier S.
        • Gordon A.R.
        • Haneuse S.
        • Potter J.E.
        • Austin S.B.
        Sexual orientation identity disparities in awareness and initiation of the human papillomavirus vaccine among U.S. women and girls: a National survey.
        Ann Intern Med. 2015; 163: 99-106
        • Charlton B.M.
        • Reisner S.L.
        • Agenor M.
        • Gordon A.R.
        • Sarda V.
        • Austin S.B.
        Sexual orientation disparities in human papillomavirus vaccination in a longitudinal cohort of U.S. males and females.
        LGBT Health. 2017; 4: 202-209
        • Agenor M.
        • Peitzmeier S.M.
        • Gordon A.R.
        • et al.
        Sexual orientation identity disparities in human papillomavirus vaccination initiation and completion among young adult US women and men.
        Cancer Causes Control. 2016; 27: 1187-1196
        • Ginsberg B.A.
        • Calderon M.
        • Seminara N.M.
        • Day D.
        A potential role for the dermatologist in the physical transformation of transgender people: A survey of attitudes and practices within the transgender community.
        J Am Acad Dermatol. 2016; 74: 303-308
        • Center of Excellence for Transgender Health, Department of Family and Community Medicine, University of California San Francisco
        Guidelines for the Primary and Gender-Affirming Care of Transgender and Gender Nonbinary People.
        2nd edition. Deutsch MB, 2016
        • Irwig M.S.
        Testosterone therapy for transgender men.
        Lancet Diabetes Endocrinol. 2017; 5: 301-311
        • Giltay E.J.
        • Gooren L.J.
        Effects of sex steroid deprivation/administration on hair growth and skin sebum production in transsexual males and females.
        J Clin Endocrinol Metab. 2000; 85: 2913-2921
        • Wierckx K.
        • Van de Peer F.
        • Verhaeghe E.
        • et al.
        Short- and long-term clinical skin effects of testosterone treatment in trans men.
        J Sex Med. 2014; 11: 222-229
        • Nakamura A.
        • Watanabe M.
        • Sugimoto M.
        • et al.
        Dose-response analysis of testosterone replacement therapy in patients with female to male gender identity disorder.
        Endocr J. 2013; 60: 275-281
        • Turrion-Merino L.
        • Urech-Garcia-de-la-Vega M.
        • Miguel-Gomez L.
        • Harto-Castano A.
        • Jaen-Olasolo P.
        Severe Acne in Female-to-Male Transgender Patients.
        JAMA Dermatol. 2015; 151: 1260-1261
        • Katz K.A.
        Transgender patients, isotretinoin, and US Food and Drug Administration-mandated risk evaluation and mitigation strategies: a prescription for inclusion.
        JAMA dermatology. 2016; 152: 513-514
        • Light A.D.
        • Obedin-Maliver J.
        • Sevelius J.M.
        • Kerns J.L.
        Transgender men who experienced pregnancy after female-to-male gender transitioning.
        Obstet Gynecol. 2014; 124: 1120-1127
        • Yeung H.
        • Chen S.C.
        • Katz K.A.
        • Stoff B.K.
        Prescribing isotretinoin in the United States for transgender individuals: ethical considerations.
        J Am Acad Dermatol. 2016; 75: 648-651
        • Moreno-Arrones O.M.
        • Becerra A.
        • Vano-Galvan S.
        Therapeutic experience with oral finasteride for androgenetic alopecia in female-to-male transgender patients.
        Clin Exp Dermatol. 2017; 42: 743-748
        • Hembree W.C.
        • Cohen-Kettenis P.T.
        • Gooren L.
        • et al.
        Endocrine treatment of gender-dysphoric/gender-incongruent persons: an Endocrine Society clinical practice guideline.
        Endocr Pract. 2017; 23: 1437
        • Ginsberg B.A.
        Dermatologic care of the transgender patient.
        Int J Womens Dermatol. 2017; 3: 65-67
        • Frey J.D.
        • Poudrier G.
        • Chiodo M.V.
        • Hazen A.
        An update on genital reconstruction options for the female-to-male transgender patient: a review of the literature.
        Plast Reconstr Surg. 2017; 139: 728-737
        • Berli J.U.
        • Knudson G.
        • Fraser L.
        • et al.
        What surgeons need to know about gender confirmation surgery when providing care for transgender individuals: a review.
        JAMA Surg. 2017; 152: 394-400
        • Peitzmeier S.
        • Gardner I.
        • Weinand J.
        • Corbet A.
        • Acevedo K.
        Health impact of chest binding among transgender adults: a community-engaged, cross-sectional study.
        Cult Health Sex. 2017; 19: 64-75
        • Erickson-Schroth L.
        Trans Bodies, Trans Selves: A Resource for the Transgender Community.
        Oxford University Press, 2014
        • Lawrence A.A.
        Patient-reported complications and functional outcomes of male-to-female sex reassignment surgery.
        Arch Sex Behav. 2006; 35: 717-727
        • Zhang W.R.
        • Garrett G.L.
        • Arron S.T.
        • Garcia M.M.
        Laser hair removal for genital gender affirming surgery.
        Transl Androl Urol. 2016; 5: 381-387
        • Liguori G.
        • Trombetta C.
        • Bucci S.
        • et al.
        Condylomata acuminata of the neovagina in a HIV-seropositive male-to-female transsexual.
        Urol Int. 2004; 73: 87-88
        • Buscema J.
        • Rosenshein N.B.
        • Shah K.
        Condylomata acuminata arising in a neovagina.
        Obstet Gynecol. 1987; 69: 528-530
        • Wasef W.
        • Sugunendran H.
        • Alawattegama A.
        Genital warts in a transsexual.
        Int J STD AIDS. 2005; 16: 388-389
        • Yang C.
        • Liu S.
        • Xu K.
        • Xiang Q.
        • Yang S.
        • Zhang X.
        Condylomata gigantea in a male transsexual.
        Int J STD AIDS. 2009; 20: 211-212
        • Fernandes H.M.
        • Manolitsas T.P.
        • Jobling T.W.
        Carcinoma of the neovagina after male-to-female reassignment.
        J Low Genit Tract Dis. 2014; 18: E43-E45
        • Harder Y.
        • Erni D.
        • Banic A.
        Squamous cell carcinoma of the penile skin in a neovagina 20 years after male-to-female reassignment.
        Br J Plast Surg. 2002; 55: 449-451
        • Rotmensch J.
        • Rosenshein N.
        • Dillon M.
        • Murphy A.
        • Woodruff J.D.
        Carcinoma arising in the neovagina: case report and review of the literature.
        Obstet Gynecol. 1983; 61: 534-536
        • Steiner E.
        • Woernle F.
        • Kuhn W.
        • et al.
        Carcinoma of the neovagina: case report and review of the literature.
        Gynecol Oncol. 2002; 84: 171-175
        • Bollo J.
        • Balla A.
        • Rodriguez Luppi C.
        • Martinez C.
        • Quaresima S.
        • Targarona E.M.
        HPV-related squamous cell carcinoma in a neovagina after male-to-female gender confirmation surgery.
        Int J STD AIDS. 2017; (956462417728856)
        • Schober J.M.
        Cancer of the neovagina.
        J Pediatr Urol. 2007; 3: 167-170
        • Ainsworth T.A.
        • Spiegel J.H.
        Quality of life of individuals with and without facial feminization surgery or gender reassignment surgery.
        Qual Life Res. 2010; 19: 1019-1024
        • Wilson E.
        • Rapues J.
        • Jin H.
        • Raymond H.F.
        The use and correlates of illicit silicone or “fillers” in a population-based sample of transwomen, San Francisco, 2013.
        J Sex Med. 2014; 11: 1717-1724
        • Benotsch E.G.
        • Zimmerman R.S.
        • Cathers L.
        • et al.
        Non-medical use of prescription drugs and HIV risk behaviour in transgender women in the Mid-Atlantic region of the United States.
        Int J STD AIDS. 2016; 27: 776-782
        • Kobrak P.
        • White B.
        Transgender Women and HIV Prevention in New York City: A Needs Assessment.
        (Available at:)
        • Paul S.
        • Goyal A.
        • Duncan L.M.
        • Smith G.P.
        Granulomatous reaction to liquid injectable silicone for gluteal enhancement: review of management options and success of doxycycline.
        Dermatol Ther. 2015; 28: 98-101
        • Ginsberg B.A.
        in: Eckstrand K.L. Ehrenfeld J.M. Lesbian, Gay, Bisexual, and Transgender Healthcare: A Clinical Guide to Preventive, Primary, and Specialist Care. Springer, 2016
        • Herbst J.H.
        • Jacobs E.D.
        • Finlayson T.J.
        • et al.
        Estimating HIV prevalence and risk behaviors of transgender persons in the United States: a systematic review.
        AIDS Behav. 2008; 12: 1-17
        • Deutsch M.B.
        • Glidden D.V.
        • Sevelius J.
        • et al.
        HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial.
        Lancet HIV. 2015; 2: e512-e519

      Linked Article